Phibro Animal Health Corporation (PAHC)
NASDAQ: PAHC · Real-Time Price · USD
21.31
-0.16 (-0.72%)
Mar 31, 2025, 3:55 PM EDT - Market open
Phibro Animal Health Market Cap
Phibro Animal Health has a market cap or net worth of $862.93 million as of March 31, 2025. Its market cap has increased by 67.36% in one year.
Market Cap
862.93M
Enterprise Value
1.57B
1-Year Change
67.36%
Ranking
Category
Stock Price
$21.31
Market Cap Chart
Since April 11, 2014, Phibro Animal Health's market cap has increased from $642.80M to $862.93M, an increase of 34.25%. That is a compound annual growth rate of 2.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 869.20M | 2.19% |
| Dec 31, 2024 | 850.60M | 81.36% |
| Dec 29, 2023 | 469.00M | -13.66% |
| Dec 30, 2022 | 543.20M | -34.32% |
| Dec 31, 2021 | 827.10M | 5.28% |
| Dec 31, 2020 | 785.60M | -21.79% |
| Dec 31, 2019 | 1.00B | -22.64% |
| Dec 31, 2018 | 1.30B | -3.54% |
| Dec 29, 2017 | 1.35B | 16.59% |
| Dec 30, 2016 | 1.15B | -2.11% |
| Dec 31, 2015 | 1.18B | -4.03% |
| Dec 31, 2014 | 1.23B | 91.19% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |